Nikolaos Kyriakidis

Publications
Public outreach and news

Articles

Article: MOLECULAR IMMUNOLOGY. 2025;182:76-82
HLA Class I and II allelic diversity among Ecuadorian transplant candidates: A comprehensive retrospective analysis
Velastegui E; Castillo ME; Ortiz F; Espin S; Espinel E; Loyola LA; Baez-Cevallos D; Kyriakidis NC; Romero-Alvarez D; Baroja I; Bastidas-Caldes C
Article: BMC VETERINARY RESEARCH. 2025;21(1):220
First report of molecular detection of chicken astrovirus (CAstV) in chicks affected with enteric disease in Ecuador through a fast RT-qPCR assay based on SYBR<sup>®</sup> Green.
Santander-Parra S; Astolfi-Ferreira C; Loor-Giler A; Kyriakidis NC; Ferreira AJP; Núñez L
Journal article: NATURE COMMUNICATIONS. 2024;15(1):2700
Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer
Baroja I; Kyriakidis NC; Halder G; Moya IM
Journal article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022;19(19):12102
Accessibility Analysis of Worldwide COVID-19-Related Information Portals
Acostar-Vargas P; Novillo-Villegas S; Salvador-Acosta B; Calvopina M; Kyriakidis N; Ortiz-Prado E; Salvador-Ullauri L
Journal article: DIAGNOSTICS. 2021;11(11):1981
Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
Guaman-Bautista LP; Moreta-Urbano E; Ona-Arias CG; Torres-Arias M; Kyriakidis NC; Malci K; Jonguitud-Borrego N; Rios-Solis L; Ramos-Martinez E; Lopez-Cortes A; Barba-Ostria C
Journal article: TROPICAL DISEASES, TRAVEL MEDICINE AND VACCINES. 2021;7(1):11
Vaccine market and production capabilities in the Americas
Ortiz-Prado E; Espin E; Vasconez J; Rodriguez-Burneo N; Kyriakidis NC; Lopez-Cortes A
Journal article: NPJ VACCINES. 2021;6(1):28
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis NC; Lopez-Cortes A; Vasconez Gonzalez E; Barreto Grimaldos A; Ortiz Prado E
Journal article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2020;98(1):115094
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Ortiz-Prado E; Simbana-Rivera K; Gomez-Barreno L; Rubio-Neira M; Guaman LP; Kyriakidis NC; Muslin C; Jaramillo AMG; Barba-Ostria C; Cevallos-Robalino D; Sanches-SanMiguel H; Unigarro L; Zalakeviciute R; Gadian N; Lopez-Cortes A
Article: RMD OPEN. 2020;6(1):e000989
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
Hedlund M; Thorlacius GE; Ivanchenko M; Ottosson V; Kyriakidis N; Lagnefeldt L; Tingstrom J; Sirsjo A; Bengtsson AA; Aronsson E; Gemzell-Danielsson K; Ronnblom L; Bergman G; Espinosa A; Sonesson S-E; Eloranta M-L; Wahren-Herlenius M
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2019;294(30):11404-11419
E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2
Anandapadamanaban M; Kyriakidis NC; Csizmok V; Wallenhammar A; Espinosa AC; Ahlner A; Round AR; Trewhella J; Moche M; Wahren-Herlenius M; Sunnerhagen M
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2015;182(1):14-22
Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjogren's Syndrome
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2014;178(3):548-560
Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Journal article: JOURNAL OF AUTOIMMUNITY. 2014;51:67-74
A comprehensive review of autoantibodies in primary Sjogren's syndrome: Clinical phenotypes and regulatory mechanisms
Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
Journal article: ARTHRITIS & RHEUMATOLOGY. 2011;63(9):2783-2789
Association of the Idiotype: Antiidiotype Antibody Ratio With the Efficacy of Intravenous Immunoglobulin Treatment for the Prevention of Recurrent Autoimmune-Associated Congenital Heart Block
Routsias JG; Kyriakidis NC; Friedman DM; Llanos C; Clancy R; Moutsopoulos HM; Buyon J; Tzioufas AG
Journal article: MOLECULAR MEDICINE. 2010;16(1-2):19-26
RNA Recognition Motif (RRM) of La/SSB: The Bridge for Interparticle Spreading of Autoimmune Response to U1-RNP
Routsias JG; Kyriakidis N; Latreille M; Tzioufas AG

All other publications

Editorial comment: AMERICAN JOURNAL OF MEDICINE. 2025;:928-929
Latin America's Battle Against Antibiotic Resistance and Cancer: A Call to Action.
Rivera-Olivero IA; Kyriakidis NC
Review: TOXINS. 2021;13(1):26
Role of Uremic Toxins in Early Vascular Ageing and Calcification
Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(9):1381-1382
European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block
Kyriakidis NC; Kockum I; Julkunen H; Hoxha A; Salomonsson S; Meneghel L; Ebbing C; Dilthey A; Eronen M; De Carolis S; Kiserud T; Ruffatti A; Kere J; Meisgen S; Wahren-Herlenius M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:182
TYPE I IFN SYSTEM ACTIVATION IN NEWBORNS EXPOSED TO ANTI-RO/SSA AUTOANTIBODIES IN UTERO
Wahren M; Hedlund M; Thorlacius GE; Ivanchenko M; Kyriakidis N; Ronnblom L; Eloranta M-L; Espinosa A; Sonesson S-E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:A7
TYPE I IFN SYSTEM ACTIVATION IN NEWBORNS EXPOSED TO ANTI-RO/SSA AUTOANTIBODIES IN UTERO
Hedlund M; Thorlacius GE; Ivanchenko M; Kyriakidis N; Ronnblom L; Eloranta M-L; Espinosa A; Sonesson S-E; Wahren-Herlenius M

Articles

All other publications

News from KI

Events from KI